Lexicon Pharmaceuticals
LXRX
#6645
Rank
โ‚น77.77 B
Marketcap
โ‚น174.69
Share price
2.20%
Change (1 day)
38.68%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -โ‚น5.65 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น41.46 Million. In 2025 the company made an earning of -โ‚น4.73 Billion, an increase over its 2024 earnings that were of -โ‚น18.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น5.65 Billion19.33%
2025 -โ‚น4.73 Billion-74.88%
2024 -โ‚น18.83 Billion13.15%
2023 -โ‚น16.64 Billion73.74%
2022 -โ‚น9.58 Billion16.16%
2021 -โ‚น8.25 Billion49.82%
2020 -โ‚น5.51 Billion-147.19%
2019 โ‚น11.65 B-203.42%
2018 -โ‚น11.28 Billion-15.31%
2017 -โ‚น13.31 Billion0.2%
2016 -โ‚น13.29 Billion2920.7%
2015 -โ‚น0.44 Billion-95.33%
2014 -โ‚น9.43 Billion-3.61%
2013 -โ‚น9.78 Billion-5.52%
2012 -โ‚น10.36 Billion-4.17%
2011 -โ‚น10.81 Billion15.5%
2010 -โ‚น9.36 Billion8.36%
2009 -โ‚น8.64 Billion-4.81%
2008 -โ‚น9.07 Billion28.79%
2007 -โ‚น7.04 Billion35.71%
2006 -โ‚น5.19 Billion52.91%
2005 -โ‚น3.4 Billion-23.89%
2004 -โ‚น4.46 Billion-24.19%
2003 -โ‚น5.88 Billion-0.48%
2002 -โ‚น5.91 Billion44.12%
2001 -โ‚น4.1 Billion23.01%
2000 -โ‚น3.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น741.85 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น104.90 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น534.09 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น42.01 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น5.72 B-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น7.45 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.19 Billion-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น4.10 B-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1.56 Billion-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA